METACARE Convertible Bond Conversion Price Adjusted from 2,650 Won to 1,855 Won... Potential Dilution Risk Increases
METACARE announced an adjustment of the conversion price for its 17th series unregistered unsecured private convertible bonds (CB) from 2,650 won to 1,855 won (effective date: 2026-05-25).
The adjustment was triggered by a decline in the market price under the contractual clause, lowering the price to the floor of 1,855 won (70% of the initial issue price of 500 won after prior adjustments).
Due to the lower conversion price, the number of shares issuable upon conversion increased by approximately 42.9% from 3,773,584 to 5,390,835 shares, expanding potential dilution.
The current stock price of 1,776 won is below the adjusted conversion price of 1,855 won, so immediate conversion is not attractive; however, if the stock price rises above the conversion price, dilution risk could materialize.
If all 10 billion won of CBs are converted, total outstanding shares would increase from 17,177,736 to 22,568,571, raising concerns about existing shareholder value dilution.
[AI Comprehensive Analysis]This conversion price adjustment is a contractual response to stock price decline, significantly increasing potential dilution without additional capital raising, which is negative for existing shareholders. Investors should closely monitor dilution impact if the stock price exceeds the conversion price in the future.
KOSPI Filing Information
Filing: Adjustment of Conversion Price, Exercise Price of Stock Subscription Rights, and Exchange Price (Notice of Disclosure)